title: The effect of pitressin on esophageal blood flow of the dog.
abstract: In a previous study on canine esophagus, we reported that intravenous infusion of isoproterenol caused mucosal (i.e., mucosal + submucosal) vasodilation only in the lower esophageal sphincter (but not in the body) and muscularis vasodilation only in the body (not in the lower esophageal sphincter). In the present study, we have investigated in dogs whether these esophageal tissues also exhibit a similar difference in their vasoconstrictory response to intravenous infusion of pitressin. All measurements were made before (basal) and after infusion of 0.02 U pitressin.min-1.kg-1 for 15 min. Pitressin significantly decreased portal venous pressure and blood flow, and increased vascular resistance of all tissues of the esophagus. This vasoconstriction of the tissues, however, was higher in the squamous mucosa of the body than in the columnar mucosa of the lower esophageal sphincter. In contrast, it was higher in the smooth muscle of the lower esophageal sphincter than in the striated muscle of the body. These data together with those of our previous report on isoproterenol demonstrate that pitressin causes a pronounced vasoconstriction in those esophageal tissues where isoproterenol had no effect. Conversely, pitressin causes least vasoconstriction in those tissues where isoproterenol produced a significant vasodilation. These differences could be the result of partial agonist actions or differences in receptor density or in receptor-effector coupling mechanism.
authors.affiliation: Gastrointestinal Diseases Research Unit, Hotel Dieu Hospital, Kingston, Ont., Canada.
authors.forename: S F
authors.initials: SF
authors.lastname: White
authors.forename: P K
authors.initials: PK
authors.lastname: Dinda
authors.forename: I T
authors.initials: IT
authors.lastname: Beck
mesh_terms: D000818:Animals; D001783:Blood Flow Velocity / Q000187:drug effects; D004285:Dogs; D004947:Esophagus / Q000098:blood supply* / Q000187:drug effects; D007262:Infusions, Intravenous; D008297:Male; D011169:Portal Vein / Q000187:drug effects; D014655:Vascular Resistance / Q000187:drug effects; D014661:Vasoconstriction / Q000187:drug effects; D014667:Vasopressins / Q000008:administration & dosage / Q000494:pharmacology*
chemical_list: D014667:Vasopressins